BRUKER CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax of $15.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax · last filed 2025-03-03
- BRUKER CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2024 was $15.80M, a 13.66% decline from fiscal 2023.
- BRUKER CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2023 was $18.30M, a 112.79% increase from fiscal 2022.
- BRUKER CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2022 was $8.60M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 12 month |
|---|---|
| 2024-12-31 | $15.80M 10-K · filed 2025-03-03 |
| 2023-12-31 | $18.30M 10-K · filed 2025-03-03 |
| 2022-12-31 | $8.60M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |